Daniela Bosshardt-Hengartner

Daniela Bosshardt-Hengartner has been a member of the Board of Directors of RepRisk since 2008. She works as an independent consultant in the area of financial analysis and business development for investment managers and corporates.  

Daniela is Chair of the Board of Directors of Galenica, a diversified healthcare firm listed at the Swiss Stock Exchange.  

She previously served as a member of the Board of Directors of Vifor Pharma, Nobel Biocare, and La-Joux Perret SA. Prior to this, Daniela was a financial analyst at the Bank am Bellevue and at M2 Capital. She also served as the Chief Financial Officer (CFO) of Bellevue Asset Management.  

Daniela holds a Swiss Federal Diploma in Pharmacy from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland.